[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Medacta USA\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100494721","m-vizion-macroscopic-radiographic-study-100494721",false,"NCT05721859","M-Vizion™ Macroscopic Radiographic Study","Medacta M-Vizion™ Macroscopic Radiographic Study, Multi-center, Post-Market Outcomes Study","Inclusion Criteria:\n\n* Must be able to read, understand, and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF).\n* Ability to understand and provide written authorization for use and disclosure of personal health information.\n* Subjects who are able and willing to comply with the study protocol and follow-up visits.\n* Patients requiring a revision total hip replacement.\n* Subjects undergoing revision THA who will receive an M-Vizion femoral component according to the indications for use.\n* Male and female patients ages 21 - 80 years of age at the time of surgery.\n\nExclusion Criteria:\n\n* Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.\n* Patients with a systemic or metabolic disorder leading to progressive bone deterioration.\n* Patients bone stock is compromised by disease or infection, which could possibly prevent adequate support and\u002For fixation to the prosthesis.\n* Patients with an active or suspected latent infection in or about the hip joint.\n* Patients that are incarcerated.","ALL","21 Years","80 Years",{"count":20,"type":21},70,"ESTIMATED","OBSERVATIONAL","Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.",[25],"Revision Hip Arthroplasty",[27,28,29],"revision","hip","arthroplasty","RECRUITING","2025-05-05",{"date":33,"type":34},"2025-05-08","ACTUAL",{"date":36,"type":34},"2022-10-12",{"date":38,"type":21},"2026-06-01",{"name":40,"class":41},"Medacta USA","INDUSTRY",7,""]